Journal
ANTIVIRAL RESEARCH
Volume 177, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.antiviral.2020.104762
Keywords
SARS-CoV-2; COVID-19; 2019-nCoV; Chloroquine; Antiviral
Categories
Ask authors/readers for more resources
Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
